An interim evaluation of efficacy and safety of the combination of panitumumab, gemcitabine, and irinotecan in patients with advanced or metastatic cholangiocarcinoma: A phase II study.
Weijing Sun
Research Funding - Amgen
Davendra Sohal
No relevant relationships to disclose
Kristine Mykulowycz
No relevant relationships to disclose
Ursina R. Teitelbaum
No relevant relationships to disclose
Nevena Damjanov
No relevant relationships to disclose
Bruce J. Giantonio
No relevant relationships to disclose
Mary Carberry
No relevant relationships to disclose
Paul Stephen Wissel
No relevant relationships to disclose
Mona Jacobs-Small
No relevant relationships to disclose
Peter James O'Dwyer
No relevant relationships to disclose